NR1H4 and metabolic dysfunction-associated steatotic liver disease: Emerging evidence suggested that inhibition of ileal FXR-FGF15 induced beneficial effects that can lead to the improvement of non-alcoholic fatty liver disease (NAFLD), obesity, and insulin resistance12–14.